Controlled Hypertension Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Controlled Hypertension clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

HypertensionUncontrolled Hypertension
Vanda Pharmaceuticals240 enrolled28 locationsNCT07090161
Recruiting
Not Applicable

Renal Pelvic Denervation Pilot Trial

Uncontrolled Hypertension
Verve Medical, Inc60 enrolled5 locationsNCT07005050
Recruiting
Phase 3

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Chronic Kidney Disease(CKD)Uncontrolled Hypertension
University Hospital, Tours720 enrolled40 locationsNCT05732727
Recruiting
Phase 2

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension
Retension Pharmaceuticals. Inc.280 enrolled3 locationsNCT07142356
Recruiting
Not Applicable

Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity

Uncontrolled Hypertension
Wake Forest University Health Sciences224 enrolled1 locationNCT07031739
Recruiting
Not Applicable

Wearable Evaluation of Ambulatory Readings for Blood Pressure

Normal Blood PressureControlled HypertensionUncontrolled Hypertension
Stephen Juraschek100 enrolled1 locationNCT06610448
Recruiting
Phase 1

SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

Uncontrolled Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.82 enrolled1 locationNCT07051603
Recruiting
Not Applicable

Remote Hypertension Management for Black Patients

Uncontrolled Hypertension
Wake Forest University Health Sciences864 enrolled1 locationNCT06527794
Recruiting
Not Applicable

Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry

HypertensionUncontrolled HypertensionNon-Adherence, Medication
Changi General Hospital100 enrolled1 locationNCT06938633